SCHEMBL3049802

SCHEMBL3049802

COc1ccc2c(OC3CC4C(=O)NCCCCC=CCCC(C(=O)O)NC(=O)C4C3)cc(-c3ccccc3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ TACR3 P29371 6/20 0.38
▸ HPGD P15428 2/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MITF O75030 1/20 0.35
▸ PAX8 Q06710 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ PLA2G2A P14555 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3049466 0.92 CTSB (0.49) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3040552 0.86 CTSB (0.43) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3049806 0.82 CTSB (0.66) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL8285112 0.82 CTSB (0.66) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3049795 0.82 CTSB (0.66) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3039920 0.81 CTSB (0.61) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3048826 0.79 CTSB (0.41) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3049467 0.79 CTSB (0.62) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL3049462 0.79 CTSB (0.62) CTSBALDH1A1KDM4ESMN1; SMN2TACR3
SCHEMBL8286271 0.79 CTSB (0.62) CTSBALDH1A1KDM4ESMN1; SMN2TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7671032-B2 HCV NS-3 serine protease inhibitors MEDIVIR AB (SE) 2010-03-02 — — US claimed
US-7671032-B2 HCV NS-3 serine protease inhibitors MEDIVIR AB (SE) 2010-03-02 — — US disclosed
EP-1713823-B1 HCV NS-3 SERINE PROTEASE INHIBITORS MEDIVIR AB (SE) 2009-11-11 — — EP disclosed
EP-1713823-A2 HCV NS-3 SERINE PROTEASE INHIBITORS Medivir Aktiebolag (SE) 2006-10-25 — — EP disclosed
WO-2005073195-A2 HCV NS-3 SERINE PROTEASE INHIBITORS MEDIVIR AB (SE) 2005-08-11 — — WO disclosed
Send feedback